MENU
IPHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Innate Pharma SA (IPHA) Earnings Date & Reports
Innate Pharma SA is a clinical-stage biotechnology company... Show more
A.I. Advisor
published Earnings
IPHA is expected to report earnings to fall 37.73% to -15 cents per share on November 05
Q3'26
Est.
$-0.15
Q2'26
Est.
$-0.24
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.22
Q4'24
Beat
by $0.10
The last earnings report on September 17 showed earnings per share of -24 cents, missing the estimate of -23 cents. With 55.72K shares outstanding, the current market capitalization sits at 180.46M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment
Industry Biotechnology
Industry
N/A
Address
117, Avenue de Luminy
Phone
+33 430303030
Employees
164
Web
https://www.innate-pharma.com